Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01987375 · ClinicalTrials.gov registry record · Phase 1
Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
A Phase 1 study, sponsored by Eben Rosenthal.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01987375: Clinical Trial Phase 1 study, sponsored by Eben Rosenthal.
NCT01987375 is a Phase 1 study that was terminated before completion, run by Eben Rosenthal. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01987375, a Phase 1 study, was terminated before completion, sponsored by Eben Rosenthal.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is an open label, single institution, Phase 1 dose-escalation study to determine the safety profile of cetuximab-IRDye800 used in subjects with head and neck squamous cell carcinoma (HNSCC) that undergo surgery with curative intent. Participants will be given a dose of an approved head and neck cancer drug (Cetuximab) along with an investigational study drug called Cetuximab-IRDye800. Cetuximab-IRDye800 is a drug that is given prior to surgery that attaches to cancer cells and appears to make them visible to the doctor when he uses a special camera during the operation. The investigators are evaluating whether or not the use of the study drug along with the special camera will better identify the cancer while patients are in the operating room.
Interventions
- DRUG Cetuximab-IRDye800
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-04-19 |
| Phase | Phase 1 |
Why NCT01987375 stopped before completion
NCT01987375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Cetuximab-IRDye800 is the first listed.
NCT01987375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01987375 about?
NCT01987375 is a clinical study titled "Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures". This study is an open label, single institution, Phase 1 dose-escalation study to determine the safety profile of cetuximab-IRDye800 used in subjects with head and neck squamous cell carcinoma (HNSCC) that undergo surgery with curative intent. Participants will be given a dose of an approved head an...
What is the current status of trial NCT01987375?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2015-11. Estimated completion is 2017-04-19.
What interventions are being tested in trial NCT01987375?
The interventions under investigation include: Cetuximab-IRDye800 (DRUG).
Who is sponsoring clinical trial NCT01987375?
This trial is sponsored by Eben Rosenthal, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01987375's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia